Adverum Biotechnologies Stock Forecast - Accumulation Distribution
| ADVM Stock | USD 6.04 0.29 5.04% |
Adverum Stock Forecast is based on your current time horizon. Although Adverum Biotechnologies' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Adverum Biotechnologies' systematic risk associated with finding meaningful patterns of Adverum Biotechnologies fundamentals over time.
Adverum |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 33822.34 | 0.0748 |
| Check Adverum Biotechnologies Volatility | Backtest Adverum Biotechnologies | Information Ratio |
Adverum Biotechnologies Trading Date Momentum
| On November 24 2024 Adverum Biotechnologies was traded for 6.04 at the closing time. The top price for the day was 6.15 and the lowest listed price was 5.69 . There was no trading activity during the period 0.0. Lack of trading volume on November 24, 2024 did not affect price variability. The overall trading delta against the current closing price is 4.80% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Adverum Biotechnologies to competition |
Other Forecasting Options for Adverum Biotechnologies
For every potential investor in Adverum, whether a beginner or expert, Adverum Biotechnologies' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Adverum Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Adverum. Basic forecasting techniques help filter out the noise by identifying Adverum Biotechnologies' price trends.Adverum Biotechnologies Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Adverum Biotechnologies stock to make a market-neutral strategy. Peer analysis of Adverum Biotechnologies could also be used in its relative valuation, which is a method of valuing Adverum Biotechnologies by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Adverum Biotechnologies Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Adverum Biotechnologies' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Adverum Biotechnologies' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Adverum Biotechnologies Market Strength Events
Market strength indicators help investors to evaluate how Adverum Biotechnologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Adverum Biotechnologies shares will generate the highest return on investment. By undertsting and applying Adverum Biotechnologies stock market strength indicators, traders can identify Adverum Biotechnologies entry and exit signals to maximize returns.
Adverum Biotechnologies Risk Indicators
The analysis of Adverum Biotechnologies' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Adverum Biotechnologies' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting adverum stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.66 | |||
| Standard Deviation | 3.49 | |||
| Variance | 12.2 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of Adverum Biotechnologies to cross-verify your projections. To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.95) | Revenue Per Share 0.059 | Quarterly Revenue Growth (0.70) | Return On Assets (0.30) | Return On Equity (0.76) |
The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adverum Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.